AMSTERDAM (dpa-AFX) - Royal Philips (PHG) said that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the new eL18-4 transducer with full solution for 'small parts' assessment, which is an ultrasound exam to detect abnormalities in the small organs that are close to the skin.
The Philips Ultimate Small Parts Solution features four key innovations that work together to help improve patient care: the eL18-4 PureWave linear array transducer, Philips MicroFlow Imaging, Philips Elastography and Philips Precision Biopsy.
The new eL18-4 transducer can also be used to assess musculoskeletal injuries. Philips will debut this latest solution, which is available on Philips EPIQ 7 and 5 and Affiniti 70 ultrasound systems, at the 16th World Federation for Ultrasound in Medicine and Biology (WFUMB) Congress in Taipei.
Copyright RTT News/dpa-AFX